Frazier Lifesciences Acquisition Corporation Unit

10.0100.00Vol 1.00K1Y Perf -2.63%
Sep 13th, 2021 18:55 DELAYED
BID9.92 ASK10.15
Open10.04 Previous Close10.01
Pre-Market- After-Market-
 - -%  - -
Target Price
- 
Analyst Rating
— — 0.00
Potential %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
25.50 
Earnings Rating
Market Cap- 
Earnings Date
-
Alpha0.01 Standard Deviation0.02
Beta-0.45 

Today's Price Range

10.0110.04

52W Range

9.5011.50

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-6.01%
1 Month
0.60%
3 Months
-0.89%
6 Months
-4.21%
1 Year
-2.63%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
FLACU10.010.00000.00
AAPL149.030.91000.61
GOOG2 904.1236.00001.26
MSFT304.825.03001.68
XOM56.421.84003.37
WFC46.640.59001.28
JNJ165.420.62000.38
FB373.92-2.6100-0.69
GE102.161.78001.77
JPM158.161.09000.69
Earnings HistoryEstimateReportedSurprise %
----
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume1.00K
Shares Outstanding0
Shares Float7.63M
Trades Count366
Dollar Volume757.25K
Avg. Volume20.49K
Avg. Weekly Volume3.58K
Avg. Monthly Volume11.49K
Avg. Quarterly Volume9.05K

Frazier Lifesciences Acquisition Corporation Unit (NASDAQ: FLACU) stock closed at 10.01 per share at the end of the most recent trading day (a 0% change compared to the prior day closing price) with a volume of 1.00K shares and market capitalization of 0.0000. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Diversified Financial Services industry, Financial Services sector and employs 4 people. Frazier Lifesciences Acquisition Corporation Unit CEO is James N. Topper.

The one-year performance of Frazier Lifesciences Acquisition Corporation Unit stock is -2.63%, while year-to-date (YTD) performance is -3.56%. FLACU stock has a five-year performance of %. Its 52-week range is between 9.5 and 11.5, which gives FLACU stock a 52-week price range ratio of 25.50%

Frazier Lifesciences Acquisition Corporation Unit currently has a PE ratio of -, a price-to-book (PB) ratio of -, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of 1.12%, a ROC of 0.99% and a ROE of 1.21%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Frazier Lifesciences Acquisition Corporation Unit, there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Frazier Lifesciences Acquisition Corporation Unit’s next earnings report date is -.

The consensus rating of Wall Street analysts for Frazier Lifesciences Acquisition Corporation Unit is (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for Frazier Lifesciences Acquisition Corporation Unit stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Frazier Lifesciences Acquisition Corporation Unit has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Frazier Lifesciences Acquisition Corporation Unit has a Sell technical analysis rating based on Technical Indicators (ADX : 16.36, ATR14 : 0.10, CCI20 : -12.43, Chaikin Money Flow : 0.10, MACD : 0.04, Money Flow Index : 95.77, ROC : 1.11, RSI : 47.46, STOCH (14,3) : 16.88, STOCH RSI : 0.00, UO : 48.81, Williams %R : -83.12), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Frazier Lifesciences Acquisition Corporation Unit in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Summary Rating---

Frazier Lifesciences Acquisition Corporation Unit

Frazier Lifesciences Acquisition Corp is a blank check company.

CEO: James N. Topper

Telephone: +1 206 621-7200

Address: 601 Union Street, Seattle 98101, WA, US

Number of employees: 4

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

54%46%

Bearish Bullish

54%46%

Bearish Bullish

56%44%

News

Stocktwits